Nektar Therapeutics · NASDAQ:NKTR
Robin Howard W sold 444 Nektar Therapeutics shares (Form 4)
Traded May 19, 2026 · Filed May 21, 2026
On May 19, 2026, Robin Howard W (Director, President & CEO) sold 444 Nektar Therapeutics shares at US$65.51 for US$29,086, leaving 75,045 shares. Filed May 21, 2026 (Form 4).
- Sold
- 444 shares
- Price
- US$65.51
- Value
- US$29,086
- Holding after
- 75,045 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 19, 2026 | Common Stock | Sale | 444 | US$65.51 | 75,045 | Direct |
Source
Related
- Nektar Therapeutics
- Robin Howard W
- Nektar Therapeutics shareholders
- Form 4 · Robin Howard W · Aug 20, 2026
- Form 4 · Robin Howard W · Jun 18, 2026
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026